BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 4414663)

  • 21. Propoxyphene jaundice.
    Daikos GK; Kosmidis JC
    JAMA; 1975 May; 232(8):835. PubMed ID: 1173188
    [No Abstract]   [Full Text] [Related]  

  • 22. Alpha-methyldopa hepatotoxicity in pregnancy.
    Ali T; Srinivasan N; Le V; Rizvi S
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):125-6. PubMed ID: 19208320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings: Liver damage in patients taking methyldopa.
    Toghill PJ; Smith PG; Benton P; Brown RC; Matthews HL
    Gut; 1974 Apr; 15(4):342-3. PubMed ID: 4834576
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoniazid hepatitis.
    Maddrey WC; Boitnott JK
    Ann Intern Med; 1973 Jul; 79(1):1-12. PubMed ID: 4721174
    [No Abstract]   [Full Text] [Related]  

  • 25. [FUNCTIONAL AND BIOPTIC STUDY OF THE LIVER IN PATIENTS EXPOSED TO FLUOTHANE ANESTHESIA].
    URSO L; DALMONTE PR; BRESCHI F; TURA S
    Minerva Anestesiol; 1964 May; 30():204-6. PubMed ID: 14181772
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis, arthritis and lupus cell phenomena caused by methyldopa.
    Eliastam M; Holmes AW
    Am J Dig Dis; 1971 Nov; 16(11):1014-8. PubMed ID: 4108488
    [No Abstract]   [Full Text] [Related]  

  • 27. Methyldopa hepatitis. Report of three cases.
    Hoyumpa AM; Connell AM
    Am J Dig Dis; 1973 Mar; 18(3):213-22. PubMed ID: 4688573
    [No Abstract]   [Full Text] [Related]  

  • 28. [Liver toxicity of laxatives. Results of exposure to phenolisatines].
    Henning H; von Braun HH; Look D; Lüders CJ; Vogel HM
    Z Gastroenterol; 1973 Mar; 11(2):75-84. PubMed ID: 4803412
    [No Abstract]   [Full Text] [Related]  

  • 29. Fulminant hepatic failure associated with methyldopa.
    Puppala AR; Steinheber FU
    Am J Gastroenterol; 1977 Dec; 68(6):578-81. PubMed ID: 77129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Halothane hepatitis.
    Qizilbash AH
    Can Med Assoc J; 1973 Jan; 108(2):171-7. PubMed ID: 4684624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in liver enzymes during treatment with diltiazem. Description of 2 cases].
    Romanò M; Colombo E; Spinelli A
    G Ital Cardiol; 1987 Feb; 17(2):149-50. PubMed ID: 2886392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Peliosis hepatis, complicating treatment with anabolic steroids (author's transl)].
    Kühböck J; Radaszkiewicz T; Walek H
    Med Klin; 1975 Oct; 70(40):1602-7. PubMed ID: 810650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphologic alterations in patients with alpha-methyldopa-induced liver damage after short- and long-term exposure.
    Arranto AJ; Sotaniemi EA
    Scand J Gastroenterol; 1981; 16(7):853-63. PubMed ID: 7323715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum alcohol dehydrogenase, an indicator of intrahepatic cholestasis.
    Mezey E; Cherrick GR; Holt PR
    N Engl J Med; 1968 Aug; 279(5):241-8. PubMed ID: 5662777
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases.
    Lewis JH; Zimmerman HJ; Benson GD; Ishak KG
    Gastroenterology; 1984 Mar; 86(3):503-13. PubMed ID: 6319220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic dysfunction in recipients of renal allografts.
    Berne TV; Chatterjee SN; Craig JR; Payne JE
    Surg Gynecol Obstet; 1975 Aug; 141(2):171-5. PubMed ID: 168654
    [No Abstract]   [Full Text] [Related]  

  • 37. Halogen sensitization of the liver: a clinical syndrome, with two case reports.
    Keown KK; Bingham HG
    Anesth Analg; 1969; 48(5):710-4. PubMed ID: 5817946
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of prolonged halothane anesthesia on some cetaceans.
    Medway W; McCormick JG; Ridgway SH; Crump JF
    J Am Vet Med Assoc; 1970 Sep; 157(5):576-82. PubMed ID: 5452075
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug-induced liver injury associated with ezetimibe therapy.
    Liu Q; Tobias H; Petrovic LM
    Dig Dis Sci; 2007 Feb; 52(2):602-5. PubMed ID: 17219067
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.
    Reynolds TB; Peters RL; Yamada S
    N Engl J Med; 1971 Oct; 285(15):813-20. PubMed ID: 4108110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.